212 related articles for article (PubMed ID: 20082306)
1. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells.
Kisfalvi K; Hurd C; Guha S; Rozengurt E
J Cell Physiol; 2010 May; 223(2):309-16. PubMed ID: 20082306
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells.
Ochi N; Tanasanvimon S; Matsuo Y; Tong Z; Sung B; Aggarwal BB; Sinnett-Smith J; Rozengurt E; Guha S
J Cell Physiol; 2011 Apr; 226(4):1074-81. PubMed ID: 20857418
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
Kisfalvi K; Guha S; Rozengurt E
J Cell Physiol; 2005 Mar; 202(3):880-90. PubMed ID: 15389644
[TBL] [Abstract][Full Text] [Related]
6. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
[TBL] [Abstract][Full Text] [Related]
7. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
[TBL] [Abstract][Full Text] [Related]
8. Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells.
Rácz GZ; Szucs A; Szlávik V; Vág J; Burghardt B; Elliott AC; Varga G
J Cell Biochem; 2006 Aug; 98(6):1667-80. PubMed ID: 16637058
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
10. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways.
Wei G; Wang M; Carr BI
J Cell Physiol; 2010 Jul; 224(1):112-9. PubMed ID: 20301194
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
13. Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer.
Ding XZ; Tong WG; Adrian TE
Oncology; 2003; 65(4):285-94. PubMed ID: 14707447
[TBL] [Abstract][Full Text] [Related]
14. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
16. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.
Harikumar KB; Kunnumakkara AB; Ochi N; Tong Z; Deorukhkar A; Sung B; Kelland L; Jamieson S; Sutherland R; Raynham T; Charles M; Bagherzadeh A; Foxton C; Boakes A; Farooq M; Maru D; Diagaradjane P; Matsuo Y; Sinnett-Smith J; Gelovani J; Krishnan S; Aggarwal BB; Rozengurt E; Ireson CR; Guha S
Mol Cancer Ther; 2010 May; 9(5):1136-46. PubMed ID: 20442301
[TBL] [Abstract][Full Text] [Related]
17. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.
Wang J; Kuiatse I; Lee AV; Pan J; Giuliano A; Cui X
Mol Cancer Res; 2010 Feb; 8(2):266-77. PubMed ID: 20145041
[TBL] [Abstract][Full Text] [Related]
18. Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
Hao F; Xu Q; Zhao Y; Stevens JV; Young SH; Sinnett-Smith J; Rozengurt E
Mol Cancer Res; 2017 Jul; 15(7):929-941. PubMed ID: 28360038
[TBL] [Abstract][Full Text] [Related]
19. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways.
Siao AC; Lin YY; Shih LJ; Tsuei YW; Chuu CP; Kuo YC; Kao YH
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C839-C857. PubMed ID: 32755450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]